Standout Papers
Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin
2004
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Finding multiple target optimal intervention in disease‐related molecular network
2008
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma
2003 Standout
Secondary immune thrombocytopenic purpura
2007
Orolingual Angiodema Associated with Alteplase Treatment of Acute Stroke: A Reappraisal
2014
Expression of Platelet Glycoprotein (GP) V in Heterologous Cells and Evidence for Its Association with GP Ibα in Forming a GP Ib-IX-V Complex on the Cell Surface
1995
Prostacyclin, Nitric Oxide, and Atherosclerosisa
1994
FLS2
2000 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Network medicine: a network-based approach to human disease
2010 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
IgG4-Related Disease
2012 Standout
Atypical Hemolytic–Uremic Syndrome
2009
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Treatment of immune‐mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: A retrospective review of 40 patients
2007
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Genetic variants in pre-eclampsia: a meta-analysis
2013
Shedding light on the cell biology of extracellular vesicles
2018 Standout
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
2009 StandoutNobel
Pre-eclampsia
2005 Standout
The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism
2003
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)
2000
Nonchannel drug targets in atrial fibrillation
2004
Prevention of Venous Thromboembolism
2004 Standout
In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis
2011 StandoutNobel
Structural and functional diversity in the leucine-rich repeat family of proteins
1996
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Prevention of Venous Thromboembolism
2008 Standout
Thrombin generation, fibrin clot formation and hemostasis
2008
IgG4-related disease
2014 Standout
IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
2009
Pre-eclampsia, the Placenta and the Maternal Systemic Inflammatory Response—A Review
2003
HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End‐Stage Renal Disease
2006
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Disseminated Intravascular Coagulation
1999 Standout
Deep vein thrombosis
2005
Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation
2006
Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation
2002
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Circulating microparticles: pathophysiology and clinical implications
2006
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Pre-eclampsia
2015 Standout
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Latest Advances in Understanding Preeclampsia
2005 StandoutScience
Purification of human von Willebrand factor–cleaving protease and its identification as a new member of the metalloproteinase family
2001
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability.
2003
A Dinucleotide Deletion Results in Defective Membrane Anchoring and Circulating Soluble Glycoprotein Ibα in a Novel Form of Bernard-Soulier Syndrome
1997
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
HOW CELLS RESPOND TO INTERFERONS
1998 Standout
COI1 : An Arabidopsis Gene Required for Jasmonate-Regulated Defense and Fertility
1998 StandoutScience
“Normal” Thrombin Generation
1999
Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
2000
Guidelines for the Primary Prevention of Stroke
2014 Standout
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Thrombin generation, a function test of the haemostaticthrombotic system
2006
Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
2000
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
2000
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Toll-related receptors and the control of antimicrobial peptide expression inDrosophila
2000 StandoutNobel
A family of human receptors structurally related to Drosophila Toll
1998 Standout
The Epidemiology of Venous Thromboembolism
2003 Standout
Annexins: From Structure to Function
2002 Standout
How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome
2000
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Venous thrombosis: a multicausal disease
1999 Standout
Secretional luciferase of the luminous shrimpOplophorus gracilirostris: cDNA cloning of a novel imidazopyrazinone luciferase
2000 StandoutNobel
The TITAN trial – Assessing the efficacy and safety of an anti-von Willebrand factor Nanobody in patients with acquired thrombotic thrombocytopenic purpura
2012
Partial amino acid sequence of purified von Willebrand factor–cleaving protease
2001
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
2011 StandoutNobel
Works of B. Brenner being referenced
Angioedema during therapy with recombinant tissue plasminogen activator.
1991
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Platelet activation in patients with antiphospholipid syndrome
1998
Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF
1990
Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene
1998
Clinical experience with Octagam, a solvent detergent (SD) virus inactivated intravenous gammaglobulin.
1996
Thromboxane A2 and Prostacyclin Generation in the Microvasculature of Patients with Atherosclerosis – Effect of Low-Dose Aspirin
1989
Variant Bernard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX
1994
Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden
1999